Evidence map›Paper›PMID 42205473›Full record

ArticleFrontiers in cellular and infection microbiology2026

Impact of

Wen Yin, Tian Zeng, Chengrui Ren, Yuting Chen, Yue Guo, Kexin Ma, Yun Zhang, Rongbin Yu, Chongcai Wang, Jizheng Cui and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wen Yin *Department of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Tian Zeng *Department of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Chengrui RenDepartment of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Yuting ChenDepartment of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Yue GuoDepartment of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Kexin MaDepartment of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Yun ZhangKey Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Rongbin YuKey Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Chongcai WangResearch and Development Department, Hainan International Travel Healthcare Center (Haikou Customs Port Clinic), Haikou, China.
Jizheng CuiDepartment of pain, Lianyungang Maternal and Child Health Hospital Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China.
Peng HuangKey Laboratory of Infectious Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.
Ming YueDepartment of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The polymorphism of killer-cell immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) genes determines the host's susceptibility to viral infections. This study aimed to investigate the impact of five single nucleotide polymorphisms (SNPs) in

Indexed as

Hepatitis CHLA-B AntigensReceptors, KIR3DL1Receptors, KIR3DS1AgedCase-Control StudiesFemaleGenetic Predisposition to DiseaseHepacivirusHumansImmunity, InnateMaleMiddle AgedPolymorphism, Single NucleotideVirus InternalizationHLA-B AntigensKIR3DL1 protein, humanKIR3DS1 protein, humanReceptors, KIR3DL1Receptors, KIR3DS1genetic polymorphismhepatitis C virushuman leukocyte antigenkiller cell immunoglobulin & dashlike receptorssusceptibility

Identifiers

PMID42205473
PMCPMC13201228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.